Medicare Proposes Using National Kidney Foundation Standards For ESRD Treatment
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS' proposed rule on end-stage renal disease conditions for coverage suggests facility-wide standards using NKF Disease Outcomes Quality Initiative clinical practice guidelines. Medicare adoption of the K/DOQI guidelines could be a positive for manufacturers of ESRD therapies.
You may also be interested in...
Shire's Fosrenol Marketing Campaign Will Follow Adderall Model
Detailing efforts for the end-stage renal disease therapy will focus on the top-prescribing nephrologists and dieticians, Shire CEO Emmens says. Company will highlight Fosrenol's high selectivity and potency to differentiate the product from Genzyme's Renagel.
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said